Dabigatran etexilate for prevention of venous thromboembolism

Thromb Haemost. 2009 Jan;101(1):2-4.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Arthroplasty, Replacement, Hip / adverse effects*
  • Arthroplasty, Replacement, Knee / adverse effects*
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / adverse effects
  • Benzimidazoles / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Dabigatran
  • Enoxaparin / administration & dosage
  • Enoxaparin / adverse effects
  • Enoxaparin / therapeutic use*
  • Hemorrhage / chemically induced
  • Humans
  • Pyridines / administration & dosage
  • Pyridines / adverse effects
  • Pyridines / therapeutic use*
  • Risk Assessment
  • Treatment Outcome
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / mortality
  • Venous Thromboembolism / prevention & control*

Substances

  • Anticoagulants
  • Benzimidazoles
  • Enoxaparin
  • Pyridines
  • Dabigatran